April 15 , 2021
1246 days
927
- The Drugs Controller General of India has approved emergency use authorisation of the Russian Vaccine, Sputnik V.
- It has now become the third vaccine to get emergency use authorisation from the drug regulator after Covishield and Covaxin.
- It was discussed in the meeting of the National Expert Group on Vaccine Administration for COVID-19 (NEGVAC).
- It was chaired by VK Paul, Member (Health), Niti Aayog.
- Sputnik Vaccine was developed by Russia in the last year.
- India is the most populated country to register the Russian vaccine.
- India has now become the 60th country to approve Sputnik V.
- India is also the leading production hub for Sputnik V.
- The Hyderabad based Indian pharma company Dr Reddy’s Lab has also inked an agreement with Russia for the supply of this vaccine in India.
- Russia is the first country in the world to register a vaccine against Coronavirus (August 2020).
Post Views:
927